Safety-Related Labeling Changes
Pulmonary adverse effects, Glomerulonephritis, Capillary leak syndrome, Splenomegaly and splenic rupture
Trade Name
Accofil
Updated Section
4.4 Special Warnings and Special Precautions for Use
Month
May,2024